133 related articles for article (PubMed ID: 34988677)
1. High tumor budding predicts a poor prognosis in resected duodenal adenocarcinoma.
Sakaguchi T; Satoi S; Hashimoto D; Yamamoto T; Yamaki S; Hirooka S; Ishida M; Ikeura T; Inoue K; Naganuma M; Ishikawa H; Sekimoto M
Surg Today; 2022 Jun; 52(6):931-940. PubMed ID: 34988677
[TBL] [Abstract][Full Text] [Related]
2. Lymph node evaluation and survival after curative-intent resection of duodenal adenocarcinoma: A matched cohort study.
Ecker BL; McMillan MT; Datta J; Dempsey DT; Karakousis GC; Fraker DL; Drebin JA; Mamtani R; Giantonio BJ; Roses RE
Eur J Cancer; 2016 Dec; 69():135-141. PubMed ID: 27821316
[TBL] [Abstract][Full Text] [Related]
3. Duodenal adenocarcinoma: clinicopathologic analysis and implications for treatment.
Poultsides GA; Huang LC; Cameron JL; Tuli R; Lan L; Hruban RH; Pawlik TM; Herman JM; Edil BH; Ahuja N; Choti MA; Wolfgang CL; Schulick RD
Ann Surg Oncol; 2012 Jun; 19(6):1928-35. PubMed ID: 22167476
[TBL] [Abstract][Full Text] [Related]
4. Surgical procedure depending on the depth of tumor invasion in duodenal cancer.
Kato Y; Takahashi S; Kinoshita T; Shibasaki H; Gotohda N; Konishi M
Jpn J Clin Oncol; 2014 Mar; 44(3):224-31. PubMed ID: 24470586
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological analysis and survival outcome of duodenal adenocarcinoma.
Kim MJ; Choi SB; Han HJ; Park PJ; Kim WB; Song TJ; Suh SO; Choi SY
Kaohsiung J Med Sci; 2014 May; 30(5):254-9. PubMed ID: 24751389
[TBL] [Abstract][Full Text] [Related]
6. Tumor Budding Detection by Immunohistochemical Staining is Not Superior to Hematoxylin and Eosin Staining for Predicting Lymph Node Metastasis in pT1 Colorectal Cancer.
Okamura T; Shimada Y; Nogami H; Kameyama H; Kobayashi T; Kosugi S; Wakai T; Ajioka Y
Dis Colon Rectum; 2016 May; 59(5):396-402. PubMed ID: 27050601
[TBL] [Abstract][Full Text] [Related]
7. KRAS G>A mutation favors poor tumor differentiation but may not be associated with prognosis in patients with curatively resected duodenal adenocarcinoma.
Fu T; Guzzetta AA; Jeschke J; Vatapalli R; Dave P; Hooker CM; Morgan R; Iacobuzio-Donahue CA; Liu B; Ahuja N
Int J Cancer; 2013 Jun; 132(11):2502-9. PubMed ID: 23065691
[TBL] [Abstract][Full Text] [Related]
8. Tumor budding in invasive breast cancer - An indispensable budding touchstone.
Kumarguru BN; Ramaswamy AS; Shaik S; Karri A; Srinivas VS; Prashant BM
Indian J Pathol Microbiol; 2020 Feb; 63(Supplement):S117-S122. PubMed ID: 32108643
[TBL] [Abstract][Full Text] [Related]
9. Surgical treatment of neuroendocrine tumors in the second portion of the duodenum: a single center experience and systematic review of the literature.
Iwasaki T; Nara S; Kishi Y; Esaki M; Shimada K; Hiraoka N
Langenbecks Arch Surg; 2017 Sep; 402(6):925-933. PubMed ID: 27915372
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the clinical efficacy of a new prognostic stratification for duodenal adenocarcinoma with that of TNM staging: The importance of T status with regard to the prognosis.
Kato T; Ono Y; Oba A; Sato T; Ito H; Inoue Y; Saiura A; Takahashi Y
Eur J Surg Oncol; 2023 Jan; 49(1):122-128. PubMed ID: 35999143
[TBL] [Abstract][Full Text] [Related]
11. Budding as a risk factor for lymph node metastasis in pT1 or pT2 well-differentiated colorectal adenocarcinoma.
Okuyama T; Oya M; Ishikawa H
Dis Colon Rectum; 2002 May; 45(5):628-34. PubMed ID: 12004212
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors of non-ampullary duodenal adenocarcinoma.
Hirashita T; Ohta M; Tada K; Saga K; Takayama H; Endo Y; Uchida H; Iwashita Y; Inomata M
Jpn J Clin Oncol; 2018 Aug; 48(8):743-747. PubMed ID: 29931295
[TBL] [Abstract][Full Text] [Related]
13. The prognostic value of tumor budding in patients who had surgery for rectal cancer with and without neoadjuvant therapy.
Şirin AH; Sökmen S; Ünlü SM; Ellidokuz H; Sarioğlu S
Tech Coloproctol; 2019 Apr; 23(4):333-342. PubMed ID: 30900039
[TBL] [Abstract][Full Text] [Related]
14. Optimal Lymphadenectomy for Duodenal Adenocarcinoma: Does the Number Alone Matter?
Sakamoto T; Saiura A; Ono Y; Mise Y; Inoue Y; Ishizawa T; Takahashi Y; Ito H
Ann Surg Oncol; 2017 Oct; 24(11):3368-3375. PubMed ID: 28799027
[TBL] [Abstract][Full Text] [Related]
15. Tumor budding is a significant indicator of a poor prognosis in lung squamous cell carcinoma patients.
Masuda R; Kijima H; Imamura N; Aruga N; Nakamura Y; Masuda D; Takeichi H; Kato N; Nakagawa T; Tanaka M; Inokuchi S; Iwazaki M
Mol Med Rep; 2012 Nov; 6(5):937-43. PubMed ID: 22940760
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcomes in patients with duodenal adenocarcinoma.
Lee SY; Lee JH; Hwang DW; Kim SC; Park KM; Lee YJ
ANZ J Surg; 2014 Dec; 84(12):970-5. PubMed ID: 23656271
[TBL] [Abstract][Full Text] [Related]
17. Prognostic relevance of lymph node ratio and number of resected nodes after curative resection of ampulla of Vater carcinoma.
Falconi M; Crippa S; Domínguez I; Barugola G; Capelli P; Marcucci S; Beghelli S; Scarpa A; Bassi C; Pederzoli P
Ann Surg Oncol; 2008 Nov; 15(11):3178-86. PubMed ID: 18712568
[TBL] [Abstract][Full Text] [Related]
18. Tumor budding correlates with occult cervical lymph node metastasis and poor prognosis in clinical early-stage tongue squamous cell carcinoma.
Xie N; Wang C; Liu X; Li R; Hou J; Chen X; Huang H
J Oral Pathol Med; 2015 Apr; 44(4):266-72. PubMed ID: 25169851
[TBL] [Abstract][Full Text] [Related]
19. Tumor budding as a strong prognostic indicator in invasive ampullary adenocarcinomas.
Ohike N; Coban I; Kim GE; Basturk O; Tajiri T; Krasinskas A; Bandyopadhyay S; Morohoshi T; Shimada Y; Kooby DA; Staley CA; Goodman M; Adsay NV
Am J Surg Pathol; 2010 Oct; 34(10):1417-24. PubMed ID: 20871215
[TBL] [Abstract][Full Text] [Related]
20. [Grading of tumor budding in intestinal-type early gastric adenocarcinoma and its role in assessing the risk of lymph node metastasis].
Zhou ZY; Guo Q; Zhou ZH
Zhonghua Bing Li Xue Za Zhi; 2021 Jul; 50(7):779-784. PubMed ID: 34405614
[No Abstract] [Full Text] [Related]
[Next] [New Search]
